Skip to main content
logo
Mabpharm Limited (HKG:2181)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.3900
-0.0300 (-7.14%)
Sep 18, 2026, 4:08 PM HKT

Mabpharm Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
769.85646.1258.2387.1655.9282.88
Revenue Growth
19.16%150.20%196.27%55.87%-32.53%-
Gross Profit
693.96573.65219.3975.2440.5466.11
Operating Income
35.874.8-119.67-201.98-226.25-297.52
Net Income
85.657.13-127.95-209.36-210.82-291.74
Earnings Per Share
0.020.01-0.03-0.05-0.05-0.07
EPS Growth
69.01%-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
93.33109.2689.34173.3548.6181.56
Total Debt
307.94326.74311.59282.57171.3446.43
Net Cash (Debt)
-214.61-217.48-222.25-109.23-122.7335.13
Net Cash Growth
------92.10%
Net Cash Per Share
-0.05-0.05-0.05-0.03-0.030.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
102.8180.78-4.157.39-56.89-199.47
Capital Expenditures
-19.1-41.09-26.14-19.04-125.13-148.67
Free Cash Flow
83.7139.7-30.2438.35-182.01-348.14
Free Cash Flow Growth
110.87%-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
90.14%88.79%84.96%86.32%72.50%79.76%
Operating Margin
4.66%0.74%-46.34%-231.74%-404.61%-358.97%
Pretax Margin
4.24%0.64%-49.55%-240.19%-377.01%-352.00%
Profit Margin
11.12%8.84%-49.55%-240.19%-377.01%-352.00%
FCF Margin
10.87%6.14%-11.71%44.00%-325.50%-420.04%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
19.9932.43----
P/FCF Ratio
16.6446.68-44.90--
PS Ratio
1.812.874.2019.7628.3840.54